Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin PK/PD and Microbiome Analysis
NCT03809260Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Gut microbiome species change at Day 19. Started Dec 2018; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03809260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809260.